Template:Factor Xa Inhibitor Reversal: Difference between revisions
Line 1: Line 1:
===Factor Xa Inhibitor Reversal===
===[[Anticoagulant reversal for life-threatening bleeds|Factor Xa Inhibitor Reversal]]===
{| {{table}}
{| {{table}}
| align="center" style="background:#f0f0f0;"|'''Anticoagulant'''
| align="center" style="background:#f0f0f0;"|'''Anticoagulant'''

Revision as of 13:15, 28 April 2016

Factor Xa Inhibitor Reversal

Anticoagulant Half-life Removed by HD Strategies to reverse or minimize anticoagulant effects
Apixaban (Eliquis®) 8-15 hrs (longer in renal impairment) No
  • If ingested within 2 hours, administer activated charcoal
  • 4-factor PCC (Kcentra™)^
    • 25units/kg—max 2500 units for treatment of documented intracranial hemorrhage
    • 50 units/kg—max 5000 units for all other life-threatening bleeds
Edoxaban (Savaysa®) 10-14 hrs (longer in renal impairment) ~ 25% As above
Rivaroxaban (Xarelto®) 9-13 hrs (longer in renal impairment) No As above
Fondaparinux (Arixtra®) 17-21 hrs (significantly longer in renal impairment) No 4-factor PCC (Kcentra™)^ 50 units/kg—max 5000 units

^Off-label

Retrieved from "https://www.wikem.org/w/index.php?title=Template:Factor_Xa_Inhibitor_Reversal&oldid=66853"